Observational Study of Musculoskeletal Patients in an Emergency Department in France (SKUAD-P)

August 8, 2024 updated by: Hôpital NOVO

Observational Study of Musculoskeletal Patients in an Emergency Department in France : a Pilot Study

The purpose of this study is to estimate the number of patients who come to the emergency department with a musculoskeletal referral, to describe the different types of diagnosis for these patients and their treatment and discharge.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

There is a crisis in the emergency department (ED) in France, as their number of consultations have constantly increased over the past ten years . Musculoskeletal disorders (MSK) are the most common cause of consultations in ED, as an example there is an average of 30% of ED consultations being for traumatic issues . Moreover, 90% of all patients coming in ED in France have a favourable prognosis of evolution (no risk of seriousness). In this situation, one of the propositions to help to reduce the ED burden is to allow a direct access to physiotherapists. They are the recommended profession to treat patients for musculoskeletal conditions and several studies showed physiotherapy assessment and treatment in an emergency service is safe and beneficial both for the patients and the hospital teams. They have reported to increase satisfaction, to reduce medications and requirement for expensive imaging on one hand, and to reduce the costs and to give more time to the medical team on the other hand This role does not exist yet in France, although more than 48 countries across the world have implemented it, and French physiotherapists are advocating for it. A recent text has been adopted by the French government allowing patients with recent ankle sprain or low back pain to self-refer to physiotherapists working in hospitals or in care home. . However, this access is very restricted, which will make the implementation difficult as it might not be sufficient to assist the ED. Moreover, there is a lack of information on the number and the type of diagnostic of patients with a MSK label coming to the ED, which makes it difficult to assess the impact this role could have on French ED.

In this context, a retrospective survey, describing how many patients with a musculoskeletal label are coming to the ED, and how they are managed, could help to estimate the worthiness of physiotherapist direct access in French ED.

Question : What is the proportion, the type of diagnostic and the management of musculoskeletal disorder in emergency department in one hospital in France?

Study Type

Observational

Enrollment (Actual)

161

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Pontoise, France, 95300
        • Emergency Service - Hôpital NOVO - Pontoise site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients suffering from musculoskeletal disorders in an emergency department

Description

Inclusion Criteria :

  • Patients aged between 18 and 68
  • Patients admitted to emergency with a triage by the Reception and Referral Nurse of 0, 1 or 2
  • Patients who consulted for one of the following reasons:

Lower limb pain (T13.9) Lower limb trauma (M79.61) Upper limb pain (T11.9) Upper limb trauma (M79.60) Spinal pain (M54.9) Lumbar or flank pain (R10.3) Diffuse/unspecific pain (R52.9) Loss of sensitivity/paraesthesia

- Patients informed of the study and who did not object

Exclusion Criteria :

  • Patients with another reason for consultation associated with the first
  • Patients under guardianship / curatorship and patients under safeguard of justice.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Data collection
Collection of various data from patients' medical file, such as demographic data, diagnostic results, discharge, treatment....
Other: Data collection
Collection of various data from patients' medical file, such as demographic data, diagnostic results, discharge, treatment....

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of the population (diagnoses and treatment) considered to have a potential musculoskeletal disorder after nursing triage
Time Frame: At the end of the study, an average of 3 month
The description of the patients, triaged by the emergency reception and referral nurse as having a potential musculoskeletal pathology, will be carried out by collecting the different types of diagnoses, based on the International Classification of Diseases - 10th revision (ICD10) and their severity, as well as their age and gender, and the treatments that have been prescribed (medication, imaging, physiotherapy, other…).
At the end of the study, an average of 3 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of the management of patients (duration) with a potential musculoskeletal disorder after nursing triage
Time Frame: At the end of the study, an average of 3 month
Collection of the duration of care (from registration at the emergency department to the patient's discharge)
At the end of the study, an average of 3 month
Description of the management of patients (number of patients per day of the week) with a potential musculoskeletal disorder after nursing triage
Time Frame: At the end of the study, an average of 3 month
Collection of the number of patients per day of the week (Monday to Sunday) and by time slots between 8am and 8pm during the day and between 8pm and 8am at night
At the end of the study, an average of 3 month
Assessment of the prevalence of people with a potential musculoskeletal disorder after nursing triage
Time Frame: At the end of the study, an average of 3 month
Number of patients with a potential musculoskeletal disorder, after nursing triage, out of the total number of people consulting during the same period
At the end of the study, an average of 3 month
Description of the management of patients (end-of-care orientation) with a potential musculoskeletal disorder after nursing triage
Time Frame: At the end of the study, an average of 3 month
Collection of different referrals (hospitalization, return home..) at the end of patient care
At the end of the study, an average of 3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hôpital NOVO

Collaborators

University of Brighton

Investigators

  • Principal Investigator: Benoit ANCEL, Hôpital NOVO

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2024

Primary Completion (Actual)

July 24, 2024

Study Completion (Actual)

July 24, 2024

Study Registration Dates

First Submitted

May 31, 2024

First Submitted That Met QC Criteria

May 31, 2024

First Posted (Actual)

June 6, 2024

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 8, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHRD0823

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe